Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that mimics a hormone your gut naturally produces to regulate blood sugar and appetite. Research shows that patients using semaglutide lose an average of 5-10% of their body weight within the first 3 months, with continued results over 6-12 months. Understanding realistic timelines helps you set proper expectations and stay committed to your personalized weight loss plan.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

When Does Semaglutide Start Working for Weight Loss?

Semaglutide begins affecting your appetite and eating patterns almost immediately after your first dose. Many patients report feeling fuller faster and losing interest in food within 3-7 days. This rapid change in hunger signals is one of the most noticeable early effects, even before the scale reflects weight loss.

Measurable weight loss—meaning a drop on the scale that reflects fat loss—typically becomes visible between week 4 and week 8 of treatment. Some individuals see results by week 2 if they have significant water weight or if their starting dose suppresses appetite very effectively. The timeline varies based on your metabolism, starting weight, diet, and activity level.

Weekly Weight Loss Rate: What You Can Realistically Expect

During months 1-3, most patients on semaglutide lose between 1-2 pounds per week when combined with healthy eating habits. This rate is considered sustainable and reduces your risk of nutrient deficiencies or metabolic slowdown. Faster initial losses often include water weight, which stabilizes as your body adjusts to the medication.

By months 3-6, weight loss may slow to 0.5-1 pound per week as your body reaches a new equilibrium. This deceleration is normal and does not mean the medication is failing—it reflects your body's natural adaptive response. Continuing with the same dose or, if needed, increasing to the next level under medical guidance helps maintain momentum toward your goal weight.

Factors That Affect How Fast You Lose Weight

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Lifestyle factors—including daily calorie intake, protein consumption, sleep quality, and exercise frequency—directly impact your weekly weight loss rate. Combining semaglutide with a high-protein diet (25-35% of daily calories) and 150 minutes of weekly moderate activity accelerates results. Alcohol consumption, stress levels, and medication interactions can also slow progress, making personalized guidance essential.

PlexusDx Semaglutide: Affordable, Accessible, and Personalized

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required, no membership fees, and HSA/FSA eligibility. All compounds are manufactured by licensed 503A compounding pharmacies and dispensed to all 50 states. Your dose may need to go up as you progress through treatment—your price won't, making long-term therapy predictable and budget-friendly.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose in my first month on semaglutide?

Most patients lose 2-5 pounds in the first month, with the bulk of this coming from reduced water weight and decreased food intake due to appetite suppression. Weight loss accelerates in months 2-3 as your body adapts and you maintain consistent calorie reduction. Your actual loss depends on starting weight, diet adherence, and how your individual GLP-1 receptor genetics respond to the medication.

Do clinical trials show consistent weight loss timelines?

Landmark trials demonstrated that semaglutide users lose an average of 5-10% of body weight by week 12 and 10-15% by week 26. Individual responses vary significantly based on dose, lifestyle, and genetic factors. PlexusDx patients benefit from access to compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan, with the option to add genetic testing to personalize your expected results.

Why is my weight loss slower than my friend's on the same medication?

Genetic differences in how your GLP-1 and GIPR receptors function directly affect medication response. Other variables include your starting metabolic rate, diet quality, sleep, stress, and existing health conditions. The Precision Peptide Genetic Test identifies which peptide pathways are most active in your body, explaining differences and helping optimize your dose and lifestyle strategy.

Is rapid weight loss on semaglutide safe?

Weight loss of 1-2 pounds per week is considered safe and sustainable by most medical guidelines. Faster losses can increase risk of muscle loss, gallstones, and nutrient deficiencies. PlexusDx recommends pairing semaglutide with adequate protein intake, hydration, and regular monitoring to protect your health while achieving your goals.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves